Novo Nordisk A/S (NVO)
132.89
+0.52
(+0.39%)
USD |
NYSE |
Mar 18, 16:00
133.32
+0.43
(+0.32%)
Pre-Market: 20:00
Novo Nordisk Price: 132.89 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 131.57 | 133.75 | 131.07 | 132.89 | 3.817M |
Mar 15, 2024 | 133.88 | 134.00 | 131.86 | 132.37 | 3.780M |
Mar 14, 2024 | 135.85 | 135.92 | 133.87 | 134.58 | 3.507M |
Mar 13, 2024 | 134.24 | 135.50 | 132.70 | 133.49 | 6.847M |
Mar 12, 2024 | 131.60 | 135.12 | 131.45 | 135.11 | 6.341M |
Mar 11, 2024 | 133.37 | 133.52 | 130.75 | 131.24 | 5.734M |
Mar 08, 2024 | 133.90 | 134.83 | 131.10 | 133.07 | 12.77M |
Mar 07, 2024 | 133.44 | 138.28 | 132.87 | 135.92 | 19.61M |
Mar 06, 2024 | 124.36 | 125.18 | 123.36 | 124.75 | 3.896M |
Mar 05, 2024 | 126.25 | 126.83 | 123.97 | 124.65 | 4.808M |
Mar 04, 2024 | 127.33 | 128.77 | 126.99 | 127.95 | 6.817M |
Mar 01, 2024 | 122.80 | 124.43 | 122.25 | 124.23 | 5.447M |
Feb 29, 2024 | 120.11 | 120.28 | 118.91 | 119.77 | 5.480M |
Feb 28, 2024 | 121.96 | 122.15 | 120.93 | 121.54 | 3.075M |
Feb 27, 2024 | 119.97 | 122.56 | 119.79 | 122.23 | 7.637M |
Feb 26, 2024 | 123.20 | 124.16 | 122.79 | 123.49 | 4.452M |
Feb 23, 2024 | 123.67 | 124.17 | 122.91 | 123.45 | 3.759M |
Feb 22, 2024 | 123.07 | 124.86 | 123.01 | 124.52 | 3.590M |
Feb 21, 2024 | 119.00 | 120.98 | 118.30 | 120.93 | 4.122M |
Feb 20, 2024 | 124.62 | 124.76 | 120.72 | 121.45 | 5.070M |
Feb 16, 2024 | 121.84 | 124.64 | 121.55 | 124.01 | 6.609M |
Feb 15, 2024 | 122.78 | 123.15 | 121.09 | 121.75 | 4.764M |
Feb 14, 2024 | 120.51 | 123.34 | 120.38 | 123.29 | 5.678M |
Feb 13, 2024 | 119.66 | 120.55 | 119.43 | 119.99 | 4.187M |
Feb 12, 2024 | 120.42 | 120.84 | 119.29 | 120.53 | 4.498M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.40
Minimum
May 16 2019
135.92
Maximum
Mar 07 2024
52.24
Average
49.48
Median
Feb 24 2022
Price Benchmarks
Regeneron Pharmaceuticals Inc | 959.72 |
Vertex Pharmaceuticals Inc | 411.10 |
Sarepta Therapeutics Inc | 123.94 |
Viking Therapeutics Inc | 63.35 |
CytomX Therapeutics Inc | 2.02 |
Price Related Metrics
PE Ratio | 49.17 |
PS Ratio | 17.72 |
PEG Ratio | 0.8769 |
Price to Book Value | 37.48 |
Price to Free Cash Flow | 58.76 |
Earnings Yield | 2.03% |
Market Cap | 593.01B |
PEGY Ratio | 0.8649 |
Operating PE Ratio | 40.11 |
Normalized PE Ratio | 49.17 |